Orchestra BioMed Holdings, Inc. Defined Contribution Plan, Cost
Orchestra BioMed Holdings, Inc. (OBIO) reported Defined Contribution Plan, Cost of $127.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. defined contribution plan, cost for the quarter ending 2026-06-30 was $127.00K, a 6.72% increase year-over-year.
- Orchestra BioMed Holdings, Inc. defined contribution plan, cost for the quarter ending 2026-03-31 was $164.00K, a 36.67% increase year-over-year.
- Orchestra BioMed Holdings, Inc. defined contribution plan, cost for the quarter ending 2025-12-31 was $83.00K, a 13.70% increase year-over-year.
- Orchestra BioMed Holdings, Inc. defined contribution plan, cost for the quarter ending 2025-09-30 was $104.00K, a 22.35% increase year-over-year.
- Orchestra BioMed Holdings, Inc. defined contribution plan, cost for fiscal 2025 was $426.00K, a 12.11% increase from fiscal 2024.
- Orchestra BioMed Holdings, Inc. defined contribution plan, cost for fiscal 2024 was $380.00K, a 9.83% increase from fiscal 2023.
- Orchestra BioMed Holdings, Inc. defined contribution plan, cost for fiscal 2023 was $346.00K.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $127.00K 10-Q · filed 2026-08-10 | $291.00K 10-Q · filed 2026-08-10 | $374.00K derived: sum of 3 quarters · filed 2026-08-10 | $478.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $164.00K 10-Q · filed 2026-05-12 | $247.00K derived: sum of 2 quarters · filed 2026-05-12 | $351.00K derived: sum of 3 quarters · filed 2026-05-12 | $470.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $187.00K derived: sum of 2 quarters · filed 2026-03-12 | $306.00K derived: sum of 3 quarters · filed 2026-08-10 | $426.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $104.00K 10-Q · filed 2025-11-10 | $223.00K derived: sum of 2 quarters · filed 2026-08-10 | $343.00K 10-Q · filed 2025-11-10 | $416.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $119.00K 10-Q · filed 2026-08-10 | $239.00K 10-Q · filed 2026-08-10 | $312.00K derived: sum of 3 quarters · filed 2026-08-10 | $397.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $120.00K 10-Q · filed 2026-05-12 | $193.00K derived: sum of 2 quarters · filed 2026-05-12 | $278.00K derived: sum of 3 quarters · filed 2026-05-12 | $413.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $158.00K derived: sum of 2 quarters · filed 2026-03-12 | $293.00K derived: sum of 3 quarters · filed 2026-03-12 | $380.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $85.00K 10-Q · filed 2025-11-10 | $220.00K derived: sum of 2 quarters · filed 2025-11-10 | $307.00K 10-Q · filed 2025-11-10 | $374.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $135.00K 10-Q · filed 2025-08-12 | $222.00K 10-Q · filed 2025-08-12 | $289.00K derived: sum of 3 quarters · filed 2025-08-12 | $387.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $87.00K 10-Q · filed 2025-05-12 | $154.00K derived: sum of 2 quarters · filed 2025-05-12 | $252.00K derived: sum of 3 quarters · filed 2025-05-12 | $319.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $165.00K derived: sum of 2 quarters · filed 2025-03-31 | $232.00K derived: sum of 3 quarters · filed 2025-03-31 | $346.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $98.00K 10-Q · filed 2024-11-12 | $165.00K derived: sum of 2 quarters · filed 2024-11-12 | $279.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $67.00K 10-Q · filed 2024-08-12 | $181.00K 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $113.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |